B. van Eerdenbrugh

Pharmaceutical Science · 2008–2010

A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom B. van Eerdenbrugh trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Müller
  2. B. Rabinow
  3. C. Keck

Who trusts B. van Eerdenbrugh overall

  1. H. Williams

Papers from B. van Eerdenbrugh's perspective

Ordered by how strongly the researchers B. van Eerdenbrugh trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (Advanced Drug Delivery Reviews)
  2. Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. (Angewandte Chemie)
  3. Nanosizing: a formulation approach for poorly-water-soluble compounds. (European Journal of Pharmaceutical Sciences)
  4. Poor aqueous solubility-an industry wide problem in drug discovery
  5. Nanosizing--oral formulation development and biopharmaceutical evaluation. (Advanced Drug Delivery Reviews)
  6. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. (European journal of pharmaceutics and biopharmaceutics)
  7. Nanosuspensions in drug delivery (Nature reviews. Drug discovery)
  8. Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles. (Journal of Biotechnology)
  9. What is the True Solubility Advantage for Amorphous Pharmaceuticals? (Pharmaceutical Research)
  10. Solid lipid nanoparticles: production, characterization and applications. (Advanced Drug Delivery Reviews)

Their papers